CVS
CVS Health·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 3
Consensus Rating "Buy"
Significant Net Income Decline
Undervalued
EPS Below Expectations
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About CVS
Cvs Health Corporation
The largest pharmacy chain in the United States
Consumer Goods Distribution and Retail
--
10/01/1952
New York Stock Exchange
300,000
12-31
Common stock
One CVS Drive, Woonsocket, Rhode Island, 02895
Prescription drug retail
Founded in Delaware in 1996, CVS Health Corporation and its affiliates are the largest pharmaceutical suppliers in the United States. CVS-Health has pioneered a whole new approach to health care by making high-quality care more economical, accessible, simpler and more seamless. CVS Health is community-based and local-centric, giving consumers access to the care they need anytime, anywhere. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, excellent pharmacy management staff, approximately 105 million plan members, a dedicated senior pharmacy care business that serves more than 1 million patients annually, and expanded specialty pharmacy services. CVS Health also serves 37 million people through traditional, voluntary and consumer-oriented health insurance products and related services, including an expanded Medicare Advantage product and a leading standalone Medicare Part D prescription drug plan (" PDP "). The Company believes that its innovative healthcare model increases access to quality healthcare services, provides better health outcomes, and reduces overall healthcare costs.
Earnings Call
Q1/2025
Estimate EPS1.67
Actual EPS2.25
Estimate Revenue93.37B
Actual Revenue94.60B
CVS Health's Q1 2025: Navigating Contradictions in Medicare Advantage, CostVantage, and Pharmacy Trends
May 14,2025 07:51
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS1.46
Actual EPS1.81
Estimate Revenue94.59B
Actual Revenue98.90B
CVS Health's 2025 Q2 Earnings Call: Key Contradictions Unveiled on Medicare Advantage and Oak Street Performance
Jul 31,2025 07:18
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS1.36
Actual EPS1.6
Estimate Revenue98.83B
Actual Revenue102.90B
CVS Health's Q3 2025: Contradictions Emerge on PBM Revenue, Medicare Advantage Margins, and PBM Transitions
Oct 29,2025 10:37
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
CVS has released its 2025 Q3 earnings. EPS was reported at 1.6, versus the expected 1.36, beating expectations. The chart below visualizes how CVS has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
CVS has released its 2025 Q3 earnings report, with revenue of 102.87B, reflecting a YoY change of 7.80%, and net profit of -3.99B, showing a YoY change of -5719.72%. The Sankey diagram below clearly presents CVS's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
